| Ident. | Authors (with country if any) | Title |
|---|
| 000038 (2021) |
María Antonela Zígolo [Argentine] ; Matías Rivero Goytia [Argentine] ; Hugo Ramiro Poma [Argentine] ; Ver Nica Beatriz Rajal [Singapour] ; Ver Nica Patricia Irazusta [Argentine] | Virtual screening of plant-derived compounds against SARS-CoV-2 viral proteins using computational tools. |
| 000055 (2021) |
Tuan V. Nguyen [Australie] | Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load. |
| 000168 (2021) |
Peyman Kheirandish Zarandi [Iran] ; Mohammad Reza Zinatizadeh [Iran] ; Maryam Zinatizadeh [Iran] ; Mohammad Hadi Yousefi [Iran] ; Nima Rezaei [Iran] | SARS-CoV-2: From the pathogenesis to potential anti-viral treatments. |
| 000193 (2021) |
Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Hervé Chaudet [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France] | Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load. |
| 000246 (2021) |
Jacobo Rogado [Espagne] ; Pedro Gull N [Espagne] ; Berta Obispo [Espagne] ; Gloria Serrano [Espagne] ; Miguel Lara [Espagne] | Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors. |
| 000312 (2021) |
Weerawat Manosuthi [Thaïlande] ; Somlerk Jeungsmarn [Thaïlande] ; Pilailuk Okada [Thaïlande] ; Pawita Suwanvattana [Thaïlande] ; Warawan Wongboot [Thaïlande] ; Unchana Thawornwan [Thaïlande] ; Lantharita Charoenpong [Thaïlande] ; Surasak Wiboonchutikul [Thaïlande] ; Sumonmal Uttayamakul [Thaïlande] ; Wannarat A. Pongpirul [Thaïlande] ; Apichat Wachirapan [Thaïlande] ; Paijit Warachit [Thaïlande] | Nasopharyngeal SARS-CoV-2 Viral Load Response among COVID-19 Patients Receiving Favipiravir. |
| 000321 (2021) |
Zakariya Kashour [Canada] ; Tarek Kashour ; Danielle Gerberi [États-Unis] ; Imad M. Tleyjeh [Arabie saoudite, États-Unis] | Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials. |
| 000328 (2021) |
R. Thirumalaisamy [Inde] ; V. Aroulmoji [Inde] ; Muhammad Nasir Iqbal [Pakistan] ; M. Deepa [Inde] ; C. Sivasankar [Inde] ; Riaz Khan [Royaume-Uni] ; T. Selvankumar [Inde] | Molecular insights of hyaluronic acid-hydroxychloroquine conjugate as a promising drug in targeting SARS-CoV-2 viral proteins. |
| 000353 (2021) |
Ji-Won Kim [Corée du Sud] ; Eun Jin Kim [Corée du Sud] ; Hyun Hee Kwon [Corée du Sud] ; Chi Young Jung [Corée du Sud] ; Kyung Chan Kim [Corée du Sud] ; Jung-Yoon Choe [Corée du Sud] ; Hyo-Lim Hong [Corée du Sud] | Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019. |
| 000475 (2021) |
S. Rakedzon [Israël] ; A. Neuberger [Israël] ; A J Domb [Israël] ; N. Petersiel [Israël] ; E. Schwartz [Israël] | From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2? |
| 000480 (2021) |
Anamika Gupta [Inde] ; Rumana Ahmad [Inde] ; Sahabjada Siddiqui [Inde] ; Kusum Yadav [Inde] ; Aditi Srivastava [Inde] ; Anchal Trivedi [Inde] ; Bilal Ahmad [Inde] ; Mohsin Ali Khan [Inde] ; Amit Kumar Shrivastava [Népal] ; Girish Kumar Singh [Inde] | Flavonol morin targets host ACE2, IMP-α, PARP-1 and viral proteins of SARS-CoV-2, SARS-CoV and MERS-CoV critical for infection and survival: a computational analysis. |
| 000494 (2021) |
Wang-Da Liu [Taïwan] ; Sui-Yuan Chang [Taïwan] ; Ting-Yuan Lan [Taïwan] ; Yen-Chun Lin [Taïwan] ; Jui-Hung Kao [Taïwan] ; Chun-Hua Liao [Taïwan] ; Ming-Jui Tsai [Taïwan] ; Po-Hsien Kuo [Taïwan] ; Yu-Shan Huang [Taïwan] ; Jann-Tay Wang [Taïwan] ; Wang-Huei Sheng [Taïwan] ; Song-Chou Hsieh [Taïwan] ; Bor-Luen Chiang [Taïwan] ; Yee-Chun Chen [Taïwan] ; Shan-Chwen Chang [Taïwan] | Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics. |
| 000540 (2021) |
Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Philippe Colson [France] ; Didier Raoult [France] | Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann. |
| 000625 (2021) |
Mi Seon Han [Corée du Sud] ; Eun Hwa Choi [Corée du Sud] ; Sung Hee Chang [Corée du Sud] ; Byoung-Lo Jin [Corée du Sud] ; Eun Joo Lee [Corée du Sud] ; Baek Nam Kim [Corée du Sud] ; Min Kyoung Kim [Corée du Sud] ; Kihyun Doo [Corée du Sud] ; Ju-Hee Seo [Corée du Sud] ; Yae-Jean Kim [Corée du Sud] ; Yeo Jin Kim [Corée du Sud] ; Ji Young Park [Corée du Sud] ; Sun Bok Suh [Corée du Sud] ; Hyunju Lee [Corée du Sud] ; Eun Young Cho [Corée du Sud] ; Dong Hyun Kim [Corée du Sud] ; Jong Min Kim [Corée du Sud] ; Hye Young Kim [Corée du Sud] ; Su Eun Park [Corée du Sud] ; Joon Kee Lee [Corée du Sud] ; Dae Sun Jo [Corée du Sud] ; Seung-Man Cho [Corée du Sud] ; Jae Hong Choi [Corée du Sud] ; Kyo Jin Jo [Corée du Sud] ; Young June Choe [Corée du Sud] ; Ki Hwan Kim [Corée du Sud] ; Jong-Hyun Kim [Corée du Sud] | Clinical Characteristics and Viral RNA Detection in Children With Coronavirus Disease 2019 in the Republic of Korea. |
| 000760 (2021) |
Jayanta Kumar Das [États-Unis] ; Subhadip Chakraborty [Inde] ; Swarup Roy [Inde] | A scheme for inferring viral-host associations based on codon usage patterns identifies the most affected signaling pathways during COVID-19. |
| 000768 (2021) |
Maheswara Rao Gokada ; Visweswara Rao Pasupuleti ; Hari Babu Bollikolla | A mini review on emerging targets and Approaches for the synthesis of Anti-Viral compounds: In perspective to COVID-19. |
| 000774 (2021) |
Arif Kivrak [Turquie] ; Berdan Ula [Turquie] ; Hilal Kivrak [Turquie] | A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2. |
| 000788 (2021) |
Chris R. Triggle [Qatar] ; Devendra Bansal [Qatar] ; Hong Ding [Qatar] ; Md Mazharul Islam [Qatar] ; Elmoubashar Abu Baker Abd Farag [Qatar] ; Hamad Abdel Hadi [Qatar] ; Ali A. Sultan [Qatar] | A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic. |
| 000792 (2021) |
Oliver James Hulme [Danemark, Royaume-Uni] ; Eric-Jan Wagenmakers [Pays-Bas] ; Per Damkier [Danemark] ; Christopher Fugl Madelung [Danemark] ; Hartwig Roman Siebner [Danemark] ; Jannik Helweg-Larsen [Danemark] ; Quentin F. Gronau [Pays-Bas] ; Thomas Lars Benfield [Danemark] ; Kristoffer Hougaard Madsen [Danemark] | A Bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with COVID-19. |
| 000844 (2020) |
Anwar M. Hashem [Arabie saoudite] ; Badrah S. Alghamdi [Arabie saoudite] ; Abdullah A. Algaissi [Arabie saoudite] ; Fahad S. Alshehri [Arabie saoudite] ; Abdullah Bukhari [Arabie saoudite] ; Mohamed A. Alfaleh [Arabie saoudite] ; Ziad A. Memish [États-Unis] | Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review. |
| 000851 (2020) |
P. Conti [Italie] ; A. Younes [Italie] | Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. |
